The Australian Regulatory Framework
Australia's Therapeutic Goods Administration (TGA) oversees the regulation of therapeutic goods, including peptides. Understanding the distinction between therapeutic use and research use is fundamental for compliance.
Research Use Classification
Peptides sold for research purposes are not classified as therapeutic goods, provided they are clearly labelled "For Research Use Only" and are not marketed for human consumption. This distinction is critical and must be maintained throughout the supply chain.
Key Compliance Points
Labelling Requirements: All research peptides must be clearly labelled with the compound name, quantity, purity, lot number, and the statement "For Research Use Only. Not for Human Consumption."
Certificate of Analysis: Reputable suppliers provide a Certificate of Analysis (CoA) with each batch, documenting purity (typically via HPLC), identity (via mass spectrometry), and other quality parameters.
Storage and Handling: Researchers must maintain appropriate storage conditions and handling protocols to ensure compound integrity and safety.
Record Keeping: Maintaining accurate records of peptide purchases, storage conditions, and research use is a best practice that supports compliance and research reproducibility.
Import Considerations
For peptides imported into Australia, additional considerations apply including customs declarations, quarantine requirements, and potential TGA scrutiny for compounds that may be classified as controlled substances.
Best Practices for Researchers
Conclusion
Navigating peptide research regulations in Australia requires attention to detail and a commitment to compliance. By understanding the regulatory framework and following best practices, researchers can conduct their work with confidence.
All products are for research purposes only. Not for human consumption.